Active substances
Dermatophagoides farinae extract + Dermatophagoides pteronyssinus extract
- SFDA 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ACARIZAX 12SQ-HDM ORALLY LYOPHILISATE | 12 SQ-HDM | Oral lyophilisate · Sublingual use | 30 Blister | SAR 323.30 | Biological · Prescription | ALK-Abello A/S | Valid |
| ORYLMYTE | 300 IR | Sublingual tablet · Sublingual use | 30 Blister | SAR 323.30 | Biological · Prescription | STALLERGENES | Valid |
Indications — CHI Daman Drug Formulary
ALLERGIC RHINITIS; ASTHMA - ALLERGIC ASTHMA ASSOCIATED WITH ALLERGIC RHINITIS
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.